Keith Limbach

2.0k total citations
32 papers, 1.2k citations indexed

About

Keith Limbach is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Keith Limbach has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Virology and 13 papers in Immunology. Recurrent topics in Keith Limbach's work include HIV Research and Treatment (12 papers), Virus-based gene therapy research (8 papers) and Mosquito-borne diseases and control (8 papers). Keith Limbach is often cited by papers focused on HIV Research and Treatment (12 papers), Virus-based gene therapy research (8 papers) and Mosquito-borne diseases and control (8 papers). Keith Limbach collaborates with scholars based in United States, Australia and Belgium. Keith Limbach's co-authors include Enzo Paoletti, Marion E. Perkus, Thomas L. Richie, Ray Wü, James Tartaglia, Scott J. Goebel, Stephen W. Davis, Gerard P. Johnson, Elizabeth Norton and Ray Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Keith Limbach

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Limbach United States 22 599 448 422 382 318 32 1.2k
María Magdalena Gherardi Argentina 21 718 1.2× 293 0.7× 607 1.4× 667 1.7× 217 0.7× 41 1.3k
Rebecca P. Sumner United Kingdom 18 637 1.1× 358 0.8× 504 1.2× 585 1.5× 293 0.9× 26 1.2k
José Luis Nájera Spain 21 825 1.4× 376 0.8× 590 1.4× 592 1.5× 272 0.9× 27 1.2k
Valgerður Andrésdóttir Iceland 19 717 1.2× 407 0.9× 603 1.4× 238 0.6× 353 1.1× 42 1.2k
R C Montelaro United States 16 472 0.8× 396 0.9× 324 0.8× 225 0.6× 315 1.0× 28 1.1k
Henk Niphuis Netherlands 23 902 1.5× 209 0.5× 693 1.6× 539 1.4× 140 0.4× 65 1.6k
Ali Javadian United States 12 414 0.7× 318 0.7× 366 0.9× 478 1.3× 182 0.6× 13 1.0k
Ingo Jordan Germany 24 253 0.4× 674 1.5× 496 1.2× 150 0.4× 535 1.7× 59 1.6k
J K Rose United States 11 185 0.3× 409 0.9× 749 1.8× 264 0.7× 514 1.6× 14 1.5k
Lizhong Luo Canada 13 341 0.6× 274 0.6× 218 0.5× 166 0.4× 99 0.3× 24 710

Countries citing papers authored by Keith Limbach

Since Specialization
Citations

This map shows the geographic impact of Keith Limbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Limbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Limbach more than expected).

Fields of papers citing papers by Keith Limbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Limbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Limbach. The network helps show where Keith Limbach may publish in the future.

Co-authorship network of co-authors of Keith Limbach

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Limbach. A scholar is included among the top collaborators of Keith Limbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Limbach. Keith Limbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganeshan, Harini, Jun Huang, María Belmonte, et al.. (2025). Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes. PLoS ONE. 20(2). e0318098–e0318098.
2.
Genito, Christopher J., Zoltán Beck, Timothy W. Phares, et al.. (2017). Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013. Vaccine. 35(31). 3865–3874. 48 indexed citations
3.
Sedegah, Martha, Bjoern Peters, Michael R. Hollingdale, et al.. (2016). Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes. PLoS ONE. 11(10). e0163026–e0163026. 12 indexed citations
4.
Aguiar, João C., John B. Sacci, Hideyuki Iriko, et al.. (2015). Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development. PLoS ONE. 10(8). e0136109–e0136109. 32 indexed citations
5.
Sedegah, Martha, Michael R. Hollingdale, Fouzia Farooq, et al.. (2014). Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes. PLoS ONE. 9(9). e106241–e106241. 49 indexed citations
6.
Bruder, Joseph T., Е. А. Семенова, Ping Chen, et al.. (2012). Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses. PLoS ONE. 7(4). e33920–e33920. 30 indexed citations
7.
Limbach, Keith, João C. Aguiar, Kalpana Gowda, et al.. (2011). Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates. Malaria Journal. 10(1). 65–65. 25 indexed citations
8.
Bruder, Joseph T., et al.. (2010). Molecular vaccines for malaria. Human Vaccines. 6(1). 54–77. 22 indexed citations
9.
Bruder, Joseph T., Noelle B. Patterson, Ping Chen, et al.. (2010). Adenovectors induce functional antibodies capable of potent inhibition of blood stage malaria parasite growth. Vaccine. 28(18). 3201–3210. 32 indexed citations
10.
Limbach, Keith & Thomas L. Richie. (2009). Viral vectors in malaria vaccine development. Parasite Immunology. 31(9). 501–519. 39 indexed citations
11.
12.
Venzon, David, Joseph Romano, Phillip D. Markham, et al.. (1999). CD8+ Lymphocyte Antiviral Activity in Monkeys Immunized with SIV Recombinant Poxvirus Vaccines: Potential Role in Vaccine Efficacy. AIDS Research and Human Retroviruses. 15(5). 461–470. 21 indexed citations
13.
Benson, John M., Claire Chougnet, Marjorie Robert-Guroff, et al.. (1998). Recombinant Vaccine-Induced Protection against the Highly Pathogenic Simian Immunodeficiency Virus SIVmac251: Dependence on Route of Challenge Exposure. Journal of Virology. 72(5). 4170–4182. 122 indexed citations
14.
Tartaglia, James, Jean‐Louis Excler, Raphaëlle El Habib, et al.. (1998). Canarypox virus-based vaccines: prime-boost strategies to induce cell-mediated and humoral immunity against HIV.. PubMed. 14 Suppl 3. S291–8. 51 indexed citations
15.
Andersson, Sören, Barbro Mäkitalo, Rigmor Thorstensson, et al.. (1996). Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 2 Recombinant Canarypox (ALVAC) Vaccine Candidate in Cynomolgus Monkeys. The Journal of Infectious Diseases. 174(5). 977–985. 40 indexed citations
16.
Limbach, Keith & Enzo Paoletti. (1996). Non-replicating expression vectors: applications in vaccine development and gene therapy. Epidemiology and Infection. 116(3). 241–256. 15 indexed citations
17.
Franchini, Genoveffa, James Tartaglia, Anita Aggarwal, et al.. (1995). Highly Attenuated HIV Type 2 Recombinant Poxviruses, but Not HIV-2 Recombinant Salmonella Vaccines, Induce Long-Lasting Protection in Rhesus Macaques. AIDS Research and Human Retroviruses. 11(8). 909–920. 48 indexed citations
18.
Limbach, Keith, et al.. (1994). Nucleotide sequence of the genes encoding the canine herpesvirus gB, gC and gD homologues. Journal of General Virology. 75(8). 2029–2039. 29 indexed citations
19.
Portetelle, Daniel, Keith Limbach, M. Mammerickx, et al.. (1991). Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Vaccine. 9(3). 194–200. 45 indexed citations
20.
Perkus, Marion E., Scott J. Goebel, Stephen W. Davis, et al.. (1990). Vaccinia virus host range genes. Virology. 179(1). 276–286. 160 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Magdalena Gherardi Breakdown of academic impact, for papers by Rebecca P. Sumner Breakdown of academic impact, for papers by José Luis Nájera Breakdown of academic impact, for papers by Valgerður Andrésdóttir Breakdown of academic impact, for papers by R C Montelaro Breakdown of academic impact, for papers by Henk Niphuis Breakdown of academic impact, for papers by Ali Javadian Breakdown of academic impact, for papers by Ingo Jordan Breakdown of academic impact, for papers by J K Rose Breakdown of academic impact, for papers by Lizhong Luo
Rankless by CCL
2026